[1]
“Development and Evaluation of Lapatinib Solid Lipid Nanoparticles in the Management of Breast Cancer”, Int. J. Pharm. Sci. Drug Res., vol. 11, no. 5, pp. 245–249, Sep. 2019, doi: 10.25004/IJPSDR.2019.110515.